VIATRIS ADVOCATE® can help you overcome the barriers that may stand between your patient and their treatment.

Co-pay Assistance
With Viatris Advocate, commercially insured patients may be able to access Ogivri® for as little as $0 co-pay
No income restrictions*
Certain limits and restrictions apply. Please see full terms and conditions here Click Here

Patient Assistance
Patients without insurance coverage for Ogivri who cannot afford their medication may be able to receive their medication free of charge.
Eligibility requirements apply based on residency, income, and other factors. Contact Viatris Advocate for more information.

Benefit Investigation:
- Research patient-specific insurance coverage, coding, and billing requirements for Ogivri® and its administration
- Verify patient cost-sharing requirements including deductible, co-pay, coinsurance, and out-of-pocket maximum, and amounts met to date
- Determine payer access requirements (e.g., specialty pharmacy, in-office dispensing, etc.)
- Prepare Summary of benefits that documents all findings

Coverage & claim
Verify appeal requirements and track status and resolution of claim request.

Prior Authorization (PA) / Reauthorization Assistance & Tracking
Assist with understanding payer-specific PA requirements, submission details, and status tracking.
Check patient insurance plan enrollment status.

Billing & Coding
Provide information about applicable billing and coding for Ogivri (trastuzumab-dkst) and its administration.
Note: Coding information is provided for informational purposes only. The physician must determine the appropriate code for each patient and payer.

Alternate Coverage Identification
Viatris Advocate may assist your patients in identifying other resources, including state programs or third-party charitable foundations, that they may wish to contact.
Experienced and caring Viatris Advocate patient access specialists are available.
Patient support services and resources are available 24 hours a day, 7 days a week, via the Viatris Advocate portal at http:/www.viatrisadvocateportal.com
Monday-Friday
9.00 am to 8.00 pm ETPhone: 1 (833) 695-2623
Fax: 1 (833) 247-2756
Learn more about this FDA-approved trastuzumab biosimilar and patient access support program.
